Sandra Boenisch serves as the Principal Financial Officer and Treasurer at ANAVEX LIFE SCIENCES CORP, a clinical-stage biopharmaceutical company focused on developing novel therapeutics for central nervous system disorders. With a robust background in finance and accounting, Boenisch has been instrumental in guiding the financial strategy and operations of the company. Her role encompasses overseeing the financial planning, budgeting, and reporting processes, ensuring the company's fiscal health and compliance with regulatory standards. Before joining ANAVEX LIFE SCIENCES CORP, Boenisch accumulated extensive experience in the financial sector, working with various organizations where she honed her skills in financial management and strategic planning. Her expertise in navigating complex financial landscapes has been a significant asset to ANAVEX, particularly as the company advances its pipeline of innovative treatments. Boenisch's leadership has been pivotal in securing the necessary funding and resources to support the company's research and development efforts, contributing to its growth and stability. In her capacity as Principal Financial Officer and Treasurer, Boenisch plays a crucial role in communicating the company's financial status to stakeholders, including investors and the board of directors. Her strategic foresight and meticulous attention to detail have helped ANAVEX maintain a strong financial position, enabling the company to pursue its mission of bringing new therapeutic options to patients with unmet medical needs. Boenisch's contributions have not only bolstered the company's financial infrastructure but have also supported its overarching goal of advancing medical science.